Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population
AbstractBackground Triple-negative breast cancer (TNBC) represents about 19% of all breast cancer cases in the Chinese population. Lack of targeted therapy contributes to the poorer outcomes compared with other breast cancer subtypes. Comprehensive genomic profiling helps to explore the clinically r...
Main Authors: | Liye Wang, Qinglian Zhai, Qianyi Lu, Kaping Lee, Qiufan Zheng, Ruoxi Hong, Shusen Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2021.1966086 |
Similar Items
-
Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer
by: Jiande Wu, et al.
Published: (2019-10-01) -
Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
by: Huang Y, et al.
Published: (2023-07-01) -
Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors
by: Ruoyan Qin, et al.
Published: (2023-02-01) -
Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
by: Marco Santoro, et al.
Published: (2022-08-01) -
Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients
by: Maram Almohaywi, et al.
Published: (2023-08-01)